Managed Healthcare

Helping managed care executives succeed every day.

[Managed Healthcare @MHExecutive]

inMIND and EPCORE FL-1 both showed PFS gains when tafasitamab or epcoritamab was added to rituximab plus lenalidomide.

Christina Poh, M.D., explains what that means for relapsed or refractory #FollicularLymphoma.

Full Episode: https://t.co/VV9KCRmW6H
#Lymphoma #Oncology

[Managed Healthcare @MHExecutive]

46% of patients with type 2 diabetes not on insulin reached A1C <7.0% with a continuous glucose monitor, vs. 24% in the control group, per a new NEJM study.

[Managed Healthcare @MHExecutive]

Join us for a postelection discussion examining what the 2026 midterm elections mean for healthcare policy and managed care leaders.

💻 Free webinar on Thursday, Nov. 5, at 12 p.m. EST 
👉  Register now: https://t.co/ianzdkD8dy

#HealthcarePolicy #ManagedCare #340BReform

[Managed Healthcare @MHExecutive]

Vision is part of burn recovery, according to Abdullah Ahmed, a research fellow at the University of Illinois Chicago Department of Ophthalmology and Visual Sciences.
Questioning patients about trouble seeing during follow-up could help identify people who need support, he said.

[Managed Healthcare @MHExecutive]

Up to 20% of glaucoma patients face severe vision loss even while in treatment for decades, but new virtual reality perimetry at-home testing may be able to change that, according to Jonathan Myers, M.D., the chief of glaucoma service at Wills Eye Hospital.

[Managed Healthcare @MHExecutive]

Get excited, HSES 2026 starts TOMORROW!🌉

The countdown is nearly over, and we can’t wait to see you there!

Register now: https://t.co/LULLajZSqY

[Managed Healthcare @MHExecutive]

Time to start packing!

We’re just 2 days away from the 2026 Health System Executive Summit in San Francisco!

We can’t wait to welcome you! Register now: https://t.co/LlgRcfl2j4

[Managed Healthcare @MHExecutive]

Just 3 days until the conversations begin.
𝟐𝟎+ 𝐒𝐩𝐞𝐚𝐤𝐞𝐫𝐬 from Providence, Sutter, UC Davis, UCSF, City of Hope and MORE!

📅 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟏𝟔 | 𝐒𝐚𝐧 𝐅𝐫𝐚𝐧𝐜𝐢𝐬𝐜𝐨

Register for FREE: https://t.co/eV6gPXXZMg
#HSES2026 #sanfrancisco #healthcareevent #managedcare

[Managed Healthcare @MHExecutive]

McKesson and private equity firm CD&R will acquire Option Care Health, the largest independent home infusion company in the U.S., in a $5.8 billion deal.
https://t.co/0EuFbi0X64

[Managed Healthcare @MHExecutive]

"The science has really outpaced our ability as a care delivery system to keep up with it." Dan Nardi of Reimagine Care on AI triage and connected devices in outpatient cancer care.
https://t.co/EvZ2QJqMCr

[Managed Healthcare @MHExecutive]

Healthcare leaders are often tasked with making difficult decisions while balancing patient outcomes, organizational priorities, regulatory requirements, and financial realities.

Join us for this keynote session!

[Managed Healthcare @MHExecutive]

New mouse data point to salt as a driver of lean MASH
https://t.co/kfQ21Vy3pX

[Managed Healthcare @MHExecutive]

UC Davis Health is checking its 340B data now so it can be ready if a rebate program takes effect Jan. 1, says chief pharmacy officer Chad Hatfield, Pharm.D., M.H.A., BCPS

[Managed Healthcare @MHExecutive]

Fewer than 1 in 5 young, commercially insured patients with first-episode psychosis adhered to antipsychotics in their first year of treatment, per a recent study published in JAMA Network Open.

You can read the full story here: https://t.co/kHv20huPdb

[Managed Healthcare @MHExecutive]

Can health systems expand access to innovative therapies while maintaining long-term financial sustainability?

Watch the full interview, https://t.co/wOuuU3ph0l

[Managed Healthcare @MHExecutive]

How can health systems prepare for the growing role of bispecifics and CAR T-cell therapies in community oncology care?

Join the conversation on October 16 in San Francisco.

[Managed Healthcare @MHExecutive]

What does supporting women’s health look like in practice?

In Part 2, we take a closer look at how Judi Health, LucyRx, and RxPreferred are approaching women’s health.

Unlock Part 2 of the full article: https://t.co/QEx1dH5QuX

[Managed Healthcare @MHExecutive]

“Head-to-head data should inform coverage decisions, but payers shouldn’t dictate therapy choice.”

Experts discuss BE BOLD and what the data means for #payers, #formularies, and first-line #PsA treatment.

Watch Here: https://t.co/lsk5tEfZdS

[Managed Healthcare @MHExecutive]

The best frontline regimen in #FollicularLymphoma isn’t the most intensive or the cheapest. It’s the one that controls disease while limiting toxicity, burden and total cost.

Watch the Whole Episode: https://t.co/ryqvG1ENnw
#Lymphoma #Oncology

[Managed Healthcare @MHExecutive]

The top barriers to AI use among community oncologists are lack of reimbursement (44%), training (43%) and funding (41%), according to a new J&J survey.
https://t.co/qxyTkTRMqx